HMG-CoA Reductase Inhibitors in the Prevention of Stroke

Author： van Mil A.H.M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.1, 2000-01, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In his comment regarding HMG CoA reductase inhibitors [statins] for stroke prevention

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

How Do HMG-CoA Reductase Inhibitors Prevent Stroke?

By Bedi A.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 7-14

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the HMG-CoA Reductase Inhibitors

By Farmer J.A.   Torre-Amione G.  

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 197-213

Adis International

Access to resources Recommend Favorite